nodes	percent_of_prediction	percent_of_DWPC	metapath
Tretinoin—CYP1A1—polycystic ovary syndrome	0.439	1	CbGaD
Tretinoin—Vitamin A—RBP4—polycystic ovary syndrome	0.00684	0.878	CrCbGaD
Tretinoin—Emotional distress—Metformin—polycystic ovary syndrome	0.00457	0.0503	CcSEcCtD
Tretinoin—RARRES1—adrenal cortex—polycystic ovary syndrome	0.00456	0.0237	CbGeAlD
Tretinoin—ALDH1A2—embryo—polycystic ovary syndrome	0.00427	0.0222	CbGeAlD
Tretinoin—CRABP1—embryo—polycystic ovary syndrome	0.00412	0.0214	CbGeAlD
Tretinoin—RARRES1—endometrium—polycystic ovary syndrome	0.00407	0.0211	CbGeAlD
Tretinoin—NR0B1—adrenal cortex—polycystic ovary syndrome	0.00393	0.0204	CbGeAlD
Tretinoin—RARRES1—uterus—polycystic ovary syndrome	0.00375	0.0195	CbGeAlD
Tretinoin—CRABP2—embryo—polycystic ovary syndrome	0.00373	0.0193	CbGeAlD
Tretinoin—RARRES1—pituitary gland—polycystic ovary syndrome	0.00369	0.0191	CbGeAlD
Tretinoin—RARRES1—adipose tissue—polycystic ovary syndrome	0.00367	0.0191	CbGeAlD
Tretinoin—Acidosis—Metformin—polycystic ovary syndrome	0.00351	0.0386	CcSEcCtD
Tretinoin—Body temperature decreased—Metformin—polycystic ovary syndrome	0.00346	0.0381	CcSEcCtD
Tretinoin—Hypothermia—Metformin—polycystic ovary syndrome	0.00346	0.0381	CcSEcCtD
Tretinoin—Gastrointestinal symptom NOS—Metformin—polycystic ovary syndrome	0.0033	0.0363	CcSEcCtD
Tretinoin—RARRES1—adrenal gland—polycystic ovary syndrome	0.00329	0.0171	CbGeAlD
Tretinoin—NR0B1—pituitary gland—polycystic ovary syndrome	0.00317	0.0165	CbGeAlD
Tretinoin—ALDH1A2—endometrium—polycystic ovary syndrome	0.00313	0.0162	CbGeAlD
Tretinoin—ALDH1A1—embryo—polycystic ovary syndrome	0.00311	0.0161	CbGeAlD
Tretinoin—RARRES1—female gonad—polycystic ovary syndrome	0.00307	0.0159	CbGeAlD
Tretinoin—Respiratory distress—Metformin—polycystic ovary syndrome	0.00306	0.0336	CcSEcCtD
Tretinoin—RARRES1—vagina—polycystic ovary syndrome	0.00305	0.0158	CbGeAlD
Tretinoin—Nail disorder—Metformin—polycystic ovary syndrome	0.00299	0.033	CcSEcCtD
Tretinoin—Upset stomach—Metformin—polycystic ovary syndrome	0.00296	0.0326	CcSEcCtD
Tretinoin—ALDH1A2—uterus—polycystic ovary syndrome	0.00288	0.0149	CbGeAlD
Tretinoin—NR0B1—adrenal gland—polycystic ovary syndrome	0.00284	0.0147	CbGeAlD
Tretinoin—ALDH1A2—pituitary gland—polycystic ovary syndrome	0.00283	0.0147	CbGeAlD
Tretinoin—ALDH1A2—adipose tissue—polycystic ovary syndrome	0.00282	0.0146	CbGeAlD
Tretinoin—CYP2C9—urine—polycystic ovary syndrome	0.00278	0.0144	CbGeAlD
Tretinoin—CRABP1—pituitary gland—polycystic ovary syndrome	0.00273	0.0142	CbGeAlD
Tretinoin—CRABP2—endometrium—polycystic ovary syndrome	0.00273	0.0142	CbGeAlD
Tretinoin—NR0B1—female gonad—polycystic ovary syndrome	0.00264	0.0137	CbGeAlD
Tretinoin—ALDH1A1—adrenal cortex—polycystic ovary syndrome	0.00255	0.0132	CbGeAlD
Tretinoin—ALDH1A2—adrenal gland—polycystic ovary syndrome	0.00253	0.0131	CbGeAlD
Tretinoin—CRABP2—pituitary gland—polycystic ovary syndrome	0.00247	0.0128	CbGeAlD
Tretinoin—NR0B1—endocrine gland—polycystic ovary syndrome	0.00246	0.0128	CbGeAlD
Tretinoin—CRABP2—adipose tissue—polycystic ovary syndrome	0.00246	0.0128	CbGeAlD
Tretinoin—ALDH1A2—female gonad—polycystic ovary syndrome	0.00236	0.0122	CbGeAlD
Tretinoin—ALDH1A2—vagina—polycystic ovary syndrome	0.00234	0.0122	CbGeAlD
Tretinoin—ALDH1A1—endometrium—polycystic ovary syndrome	0.00227	0.0118	CbGeAlD
Tretinoin—CRABP1—vagina—polycystic ovary syndrome	0.00226	0.0117	CbGeAlD
Tretinoin—CYP4A11—vagina—polycystic ovary syndrome	0.00226	0.0117	CbGeAlD
Tretinoin—Contusion—Metformin—polycystic ovary syndrome	0.00223	0.0245	CcSEcCtD
Tretinoin—CRABP2—adrenal gland—polycystic ovary syndrome	0.00221	0.0114	CbGeAlD
Tretinoin—Chest discomfort—Metformin—polycystic ovary syndrome	0.00219	0.0242	CcSEcCtD
Tretinoin—ALDH1A2—endocrine gland—polycystic ovary syndrome	0.00219	0.0114	CbGeAlD
Tretinoin—RXRG—pituitary gland—polycystic ovary syndrome	0.00216	0.0112	CbGeAlD
Tretinoin—RXRG—adipose tissue—polycystic ovary syndrome	0.00215	0.0111	CbGeAlD
Tretinoin—CYP3A4—urine—polycystic ovary syndrome	0.00212	0.011	CbGeAlD
Tretinoin—CRABP1—endocrine gland—polycystic ovary syndrome	0.00211	0.011	CbGeAlD
Tretinoin—CYP4A11—endocrine gland—polycystic ovary syndrome	0.00211	0.011	CbGeAlD
Tretinoin—ALDH1A1—uterus—polycystic ovary syndrome	0.00209	0.0109	CbGeAlD
Tretinoin—ALDH1A1—pituitary gland—polycystic ovary syndrome	0.00206	0.0107	CbGeAlD
Tretinoin—CRABP2—female gonad—polycystic ovary syndrome	0.00206	0.0107	CbGeAlD
Tretinoin—ALDH1A1—adipose tissue—polycystic ovary syndrome	0.00205	0.0106	CbGeAlD
Tretinoin—RXRA—female gonad—polycystic ovary syndrome	0.00205	0.0106	CbGeAlD
Tretinoin—CRABP2—vagina—polycystic ovary syndrome	0.00204	0.0106	CbGeAlD
Tretinoin—RARB—adrenal gland—polycystic ovary syndrome	0.00197	0.0102	CbGeAlD
Tretinoin—RXRG—adrenal gland—polycystic ovary syndrome	0.00193	0.01	CbGeAlD
Tretinoin—CRABP2—endocrine gland—polycystic ovary syndrome	0.00191	0.00992	CbGeAlD
Tretinoin—RXRA—endocrine gland—polycystic ovary syndrome	0.0019	0.00988	CbGeAlD
Tretinoin—RARA—endometrium—polycystic ovary syndrome	0.00187	0.00971	CbGeAlD
Tretinoin—RARB—female gonad—polycystic ovary syndrome	0.00184	0.00954	CbGeAlD
Tretinoin—ALDH1A1—adrenal gland—polycystic ovary syndrome	0.00184	0.00953	CbGeAlD
Tretinoin—RARG—uterus—polycystic ovary syndrome	0.00183	0.00951	CbGeAlD
Tretinoin—RARB—vagina—polycystic ovary syndrome	0.00183	0.00948	CbGeAlD
Tretinoin—RXRB—adrenal gland—polycystic ovary syndrome	0.00181	0.0094	CbGeAlD
Tretinoin—RARG—adipose tissue—polycystic ovary syndrome	0.00179	0.0093	CbGeAlD
Tretinoin—Lightheadedness—Metformin—polycystic ovary syndrome	0.00174	0.0191	CcSEcCtD
Tretinoin—RARA—uterus—polycystic ovary syndrome	0.00172	0.00895	CbGeAlD
Tretinoin—ALDH1A1—female gonad—polycystic ovary syndrome	0.00171	0.00889	CbGeAlD
Tretinoin—RARB—endocrine gland—polycystic ovary syndrome	0.00171	0.00887	CbGeAlD
Tretinoin—ALDH1A1—vagina—polycystic ovary syndrome	0.0017	0.00884	CbGeAlD
Tretinoin—RARA—pituitary gland—polycystic ovary syndrome	0.00169	0.00878	CbGeAlD
Tretinoin—RXRB—female gonad—polycystic ovary syndrome	0.00169	0.00877	CbGeAlD
Tretinoin—RARA—adipose tissue—polycystic ovary syndrome	0.00169	0.00875	CbGeAlD
Tretinoin—RXRB—vagina—polycystic ovary syndrome	0.00168	0.00871	CbGeAlD
Tretinoin—RXRG—endocrine gland—polycystic ovary syndrome	0.00167	0.00867	CbGeAlD
Tretinoin—Ear pain—Metformin—polycystic ovary syndrome	0.00165	0.0182	CcSEcCtD
Tretinoin—RARG—adrenal gland—polycystic ovary syndrome	0.00161	0.00835	CbGeAlD
Tretinoin—ALDH1A1—endocrine gland—polycystic ovary syndrome	0.00159	0.00827	CbGeAlD
Tretinoin—RXRB—endocrine gland—polycystic ovary syndrome	0.00157	0.00815	CbGeAlD
Tretinoin—Nasal congestion—Metformin—polycystic ovary syndrome	0.00155	0.017	CcSEcCtD
Tretinoin—RARA—adrenal gland—polycystic ovary syndrome	0.00151	0.00785	CbGeAlD
Tretinoin—RARG—female gonad—polycystic ovary syndrome	0.0015	0.00778	CbGeAlD
Tretinoin—CYP2C18—vagina—polycystic ovary syndrome	0.0015	0.00777	CbGeAlD
Tretinoin—RARG—vagina—polycystic ovary syndrome	0.00149	0.00774	CbGeAlD
Tretinoin—Renal impairment—Metformin—polycystic ovary syndrome	0.00148	0.0163	CcSEcCtD
Tretinoin—Lethargy—Metformin—polycystic ovary syndrome	0.00144	0.0158	CcSEcCtD
Tretinoin—RARA—female gonad—polycystic ovary syndrome	0.00141	0.00732	CbGeAlD
Tretinoin—Pain in extremity—Metformin—polycystic ovary syndrome	0.00141	0.0155	CcSEcCtD
Tretinoin—CYP2C18—endocrine gland—polycystic ovary syndrome	0.0014	0.00727	CbGeAlD
Tretinoin—CYP3A7—endocrine gland—polycystic ovary syndrome	0.00133	0.00691	CbGeAlD
Tretinoin—RARA—endocrine gland—polycystic ovary syndrome	0.00131	0.0068	CbGeAlD
Tretinoin—Dehydration—Metformin—polycystic ovary syndrome	0.00131	0.0144	CcSEcCtD
Tretinoin—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00126	0.0139	CcSEcCtD
Tretinoin—Abdominal distension—Metformin—polycystic ovary syndrome	0.00123	0.0135	CcSEcCtD
Tretinoin—Pancreatitis—Metformin—polycystic ovary syndrome	0.00119	0.0131	CcSEcCtD
Tretinoin—CYP2A6—adipose tissue—polycystic ovary syndrome	0.00119	0.00617	CbGeAlD
Tretinoin—Sweating increased—Metformin—polycystic ovary syndrome	0.00119	0.0131	CcSEcCtD
Tretinoin—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00117	0.0129	CcSEcCtD
Tretinoin—Neutropenia—Metformin—polycystic ovary syndrome	0.00114	0.0125	CcSEcCtD
Tretinoin—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00113	0.0125	CcSEcCtD
Tretinoin—Infestation NOS—Metformin—polycystic ovary syndrome	0.00109	0.012	CcSEcCtD
Tretinoin—Infestation—Metformin—polycystic ovary syndrome	0.00109	0.012	CcSEcCtD
Tretinoin—Drowsiness—Metformin—polycystic ovary syndrome	0.00109	0.012	CcSEcCtD
Tretinoin—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00106	0.0117	CcSEcCtD
Tretinoin—CYP2A6—vagina—polycystic ovary syndrome	0.000989	0.00513	CbGeAlD
Tretinoin—Hepatitis—Metformin—polycystic ovary syndrome	0.000975	0.0107	CcSEcCtD
Tretinoin—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00097	0.0107	CcSEcCtD
Tretinoin—Oedema peripheral—Metformin—polycystic ovary syndrome	0.000961	0.0106	CcSEcCtD
Tretinoin—Vitamin A—CYP1A1—polycystic ovary syndrome	0.000947	0.122	CrCbGaD
Tretinoin—Eye disorder—Metformin—polycystic ovary syndrome	0.000911	0.01	CcSEcCtD
Tretinoin—Flushing—Metformin—polycystic ovary syndrome	0.000905	0.00996	CcSEcCtD
Tretinoin—Angiopathy—Metformin—polycystic ovary syndrome	0.000885	0.00974	CcSEcCtD
Tretinoin—Chills—Metformin—polycystic ovary syndrome	0.000875	0.00963	CcSEcCtD
Tretinoin—Malnutrition—Metformin—polycystic ovary syndrome	0.000849	0.00934	CcSEcCtD
Tretinoin—Erythema—Metformin—polycystic ovary syndrome	0.000849	0.00934	CcSEcCtD
Tretinoin—Flatulence—Metformin—polycystic ovary syndrome	0.000836	0.00921	CcSEcCtD
Tretinoin—Vision blurred—Metformin—polycystic ovary syndrome	0.0008	0.00881	CcSEcCtD
Tretinoin—Tremor—Metformin—polycystic ovary syndrome	0.000795	0.00875	CcSEcCtD
Tretinoin—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000788	0.00867	CcSEcCtD
Tretinoin—Malaise—Metformin—polycystic ovary syndrome	0.000766	0.00843	CcSEcCtD
Tretinoin—Syncope—Metformin—polycystic ovary syndrome	0.000761	0.00838	CcSEcCtD
Tretinoin—Palpitations—Metformin—polycystic ovary syndrome	0.00075	0.00826	CcSEcCtD
Tretinoin—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000746	0.00821	CcSEcCtD
Tretinoin—CYP2B6—adrenal cortex—polycystic ovary syndrome	0.000745	0.00386	CbGeAlD
Tretinoin—CYP2C8—endometrium—polycystic ovary syndrome	0.000741	0.00385	CbGeAlD
Tretinoin—Hypertension—Metformin—polycystic ovary syndrome	0.000733	0.00807	CcSEcCtD
Tretinoin—Myalgia—Metformin—polycystic ovary syndrome	0.000723	0.00795	CcSEcCtD
Tretinoin—Chest pain—Metformin—polycystic ovary syndrome	0.000723	0.00795	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000718	0.0079	CcSEcCtD
Tretinoin—Discomfort—Metformin—polycystic ovary syndrome	0.000714	0.00786	CcSEcCtD
Tretinoin—Oedema—Metformin—polycystic ovary syndrome	0.000693	0.00763	CcSEcCtD
Tretinoin—Infection—Metformin—polycystic ovary syndrome	0.000688	0.00758	CcSEcCtD
Tretinoin—Shock—Metformin—polycystic ovary syndrome	0.000682	0.0075	CcSEcCtD
Tretinoin—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000679	0.00748	CcSEcCtD
Tretinoin—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000678	0.00747	CcSEcCtD
Tretinoin—Skin disorder—Metformin—polycystic ovary syndrome	0.000673	0.00741	CcSEcCtD
Tretinoin—CYP2C8—pituitary gland—polycystic ovary syndrome	0.000671	0.00348	CbGeAlD
Tretinoin—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00067	0.00737	CcSEcCtD
Tretinoin—Anorexia—Metformin—polycystic ovary syndrome	0.00066	0.00727	CcSEcCtD
Tretinoin—Hypotension—Metformin—polycystic ovary syndrome	0.000647	0.00713	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000631	0.00695	CcSEcCtD
Tretinoin—CYP1A1—uterus—polycystic ovary syndrome	0.00063	0.00327	CbGeAlD
Tretinoin—Paraesthesia—Metformin—polycystic ovary syndrome	0.000622	0.00685	CcSEcCtD
Tretinoin—Dyspnoea—Metformin—polycystic ovary syndrome	0.000618	0.0068	CcSEcCtD
Tretinoin—CYP1A1—adipose tissue—polycystic ovary syndrome	0.000617	0.0032	CbGeAlD
Tretinoin—Somnolence—Metformin—polycystic ovary syndrome	0.000616	0.00678	CcSEcCtD
Tretinoin—Dyspepsia—Metformin—polycystic ovary syndrome	0.00061	0.00671	CcSEcCtD
Tretinoin—CYP3A5—adipose tissue—polycystic ovary syndrome	0.000603	0.00313	CbGeAlD
Tretinoin—Decreased appetite—Metformin—polycystic ovary syndrome	0.000602	0.00663	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000598	0.00658	CcSEcCtD
Tretinoin—Fatigue—Metformin—polycystic ovary syndrome	0.000597	0.00657	CcSEcCtD
Tretinoin—Constipation—Metformin—polycystic ovary syndrome	0.000592	0.00652	CcSEcCtD
Tretinoin—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000571	0.00628	CcSEcCtD
Tretinoin—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000567	0.00624	CcSEcCtD
Tretinoin—CYP2C8—vagina—polycystic ovary syndrome	0.000555	0.00288	CbGeAlD
Tretinoin—Urticaria—Metformin—polycystic ovary syndrome	0.00055	0.00606	CcSEcCtD
Tretinoin—Abdominal pain—Metformin—polycystic ovary syndrome	0.000548	0.00603	CcSEcCtD
Tretinoin—CYP2B6—adrenal gland—polycystic ovary syndrome	0.000537	0.00279	CbGeAlD
Tretinoin—CYP2C8—endocrine gland—polycystic ovary syndrome	0.00052	0.0027	CbGeAlD
Tretinoin—CYP1A1—female gonad—polycystic ovary syndrome	0.000516	0.00268	CbGeAlD
Tretinoin—CYP1A1—vagina—polycystic ovary syndrome	0.000513	0.00266	CbGeAlD
Tretinoin—CYP3A5—female gonad—polycystic ovary syndrome	0.000504	0.00262	CbGeAlD
Tretinoin—CYP3A5—vagina—polycystic ovary syndrome	0.000501	0.0026	CbGeAlD
Tretinoin—CYP2B6—vagina—polycystic ovary syndrome	0.000498	0.00258	CbGeAlD
Tretinoin—Asthenia—Metformin—polycystic ovary syndrome	0.000497	0.00547	CcSEcCtD
Tretinoin—Pruritus—Metformin—polycystic ovary syndrome	0.00049	0.00539	CcSEcCtD
Tretinoin—CYP1A1—endocrine gland—polycystic ovary syndrome	0.00048	0.00249	CbGeAlD
Tretinoin—Diarrhoea—Metformin—polycystic ovary syndrome	0.000474	0.00522	CcSEcCtD
Tretinoin—CYP3A5—endocrine gland—polycystic ovary syndrome	0.000469	0.00243	CbGeAlD
Tretinoin—CYP2B6—endocrine gland—polycystic ovary syndrome	0.000466	0.00242	CbGeAlD
Tretinoin—CYP2C9—endocrine gland—polycystic ovary syndrome	0.000462	0.00239	CbGeAlD
Tretinoin—Dizziness—Metformin—polycystic ovary syndrome	0.000458	0.00504	CcSEcCtD
Tretinoin—Vomiting—Metformin—polycystic ovary syndrome	0.00044	0.00485	CcSEcCtD
Tretinoin—Rash—Metformin—polycystic ovary syndrome	0.000437	0.00481	CcSEcCtD
Tretinoin—Dermatitis—Metformin—polycystic ovary syndrome	0.000436	0.0048	CcSEcCtD
Tretinoin—Headache—Metformin—polycystic ovary syndrome	0.000434	0.00478	CcSEcCtD
Tretinoin—Nausea—Metformin—polycystic ovary syndrome	0.000412	0.00453	CcSEcCtD
Tretinoin—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000352	0.00183	CbGeAlD
Tretinoin—RXRA—Metabolism—CYP17A1—polycystic ovary syndrome	2.33e-05	8.64e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—HSD3B2—polycystic ovary syndrome	2.33e-05	8.62e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—SRD5A1—polycystic ovary syndrome	2.33e-05	8.62e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—CYP19A1—polycystic ovary syndrome	2.32e-05	8.62e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PNPLA2—polycystic ovary syndrome	2.32e-05	8.59e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—AR—polycystic ovary syndrome	2.31e-05	8.55e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—STAR—polycystic ovary syndrome	2.27e-05	8.41e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—AKR1C1—polycystic ovary syndrome	2.25e-05	8.35e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—TH—polycystic ovary syndrome	2.22e-05	8.23e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—STAR—polycystic ovary syndrome	2.22e-05	8.22e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	2.21e-05	8.21e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—SRD5A1—polycystic ovary syndrome	2.2e-05	8.14e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—LHB—polycystic ovary syndrome	2.18e-05	8.08e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—SLC2A4—polycystic ovary syndrome	2.16e-05	8.01e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	2.14e-05	7.93e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—HSD3B2—polycystic ovary syndrome	2.13e-05	7.9e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PNPLA2—polycystic ovary syndrome	2.12e-05	7.87e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	2.11e-05	7.82e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	2.1e-05	7.79e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—STAR—polycystic ovary syndrome	2.1e-05	7.77e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—GNAS—polycystic ovary syndrome	2.08e-05	7.69e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—SULT2A1—polycystic ovary syndrome	2.07e-05	7.68e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	2.07e-05	7.68e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—AKR1C1—polycystic ovary syndrome	2.06e-05	7.65e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	2.06e-05	7.65e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	2.06e-05	7.65e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—CYP19A1—polycystic ovary syndrome	2.03e-05	7.53e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—HMMR—polycystic ovary syndrome	2.02e-05	7.5e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—NCOR1—polycystic ovary syndrome	2.02e-05	7.47e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—TH—polycystic ovary syndrome	2.02e-05	7.47e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—SRD5A1—polycystic ovary syndrome	2.01e-05	7.46e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—RRM2—polycystic ovary syndrome	2.01e-05	7.44e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	1.98e-05	7.35e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—HMMR—polycystic ovary syndrome	1.98e-05	7.33e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—NCOR1—polycystic ovary syndrome	1.98e-05	7.33e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—SLC2A4—polycystic ovary syndrome	1.96e-05	7.27e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	1.95e-05	7.24e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—YAP1—polycystic ovary syndrome	1.94e-05	7.17e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—HSD3B1—polycystic ovary syndrome	1.93e-05	7.15e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—STAR—polycystic ovary syndrome	1.92e-05	7.12e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—SULT2A1—polycystic ovary syndrome	1.9e-05	7.04e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	1.9e-05	7.04e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—HSD3B1—polycystic ovary syndrome	1.89e-05	6.99e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	1.88e-05	6.98e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—CYP1A1—polycystic ovary syndrome	1.87e-05	6.95e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—HMMR—polycystic ovary syndrome	1.87e-05	6.92e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—NR3C1—polycystic ovary syndrome	1.87e-05	6.91e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—NAMPT—polycystic ovary syndrome	1.86e-05	6.89e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—CYP19A1—polycystic ovary syndrome	1.84e-05	6.83e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—RRM2—polycystic ovary syndrome	1.84e-05	6.82e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CYP11A1—polycystic ovary syndrome	1.84e-05	6.81e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—GNAS—polycystic ovary syndrome	1.81e-05	6.72e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—HSD3B1—polycystic ovary syndrome	1.78e-05	6.6e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—YAP1—polycystic ovary syndrome	1.77e-05	6.57e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.76e-05	6.53e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—LHB—polycystic ovary syndrome	1.76e-05	6.52e-05	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—VEGFA—polycystic ovary syndrome	1.75e-05	6.49e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—MTHFR—polycystic ovary syndrome	1.75e-05	6.47e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—AKR1C3—polycystic ovary syndrome	1.73e-05	6.43e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	1.73e-05	6.41e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—NCOR1—polycystic ovary syndrome	1.73e-05	6.4e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	1.72e-05	6.38e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	1.72e-05	6.38e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—LHB—polycystic ovary syndrome	1.72e-05	6.38e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—HSD3B2—polycystic ovary syndrome	1.72e-05	6.37e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—HMMR—polycystic ovary syndrome	1.71e-05	6.35e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CYP17A1—polycystic ovary syndrome	1.71e-05	6.33e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—NAMPT—polycystic ovary syndrome	1.7e-05	6.32e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CYP11A1—polycystic ovary syndrome	1.68e-05	6.24e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—HSD3B2—polycystic ovary syndrome	1.68e-05	6.23e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—AKR1C1—polycystic ovary syndrome	1.67e-05	6.17e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—GNAS—polycystic ovary syndrome	1.65e-05	6.1e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	1.64e-05	6.08e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—CYP1A1—polycystic ovary syndrome	1.64e-05	6.07e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—HSD3B1—polycystic ovary syndrome	1.63e-05	6.06e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—AKR1C1—polycystic ovary syndrome	1.63e-05	6.03e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—LHB—polycystic ovary syndrome	1.63e-05	6.02e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.61e-05	5.99e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	1.6e-05	5.93e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	1.6e-05	5.91e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—AKR1C3—polycystic ovary syndrome	1.59e-05	5.89e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—HSD3B2—polycystic ovary syndrome	1.59e-05	5.89e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—NCOR1—polycystic ovary syndrome	1.57e-05	5.81e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CYP17A1—polycystic ovary syndrome	1.56e-05	5.8e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	1.56e-05	5.8e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	1.55e-05	5.73e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—AKR1C1—polycystic ovary syndrome	1.54e-05	5.7e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—SULT2A1—polycystic ovary syndrome	1.53e-05	5.68e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.53e-05	5.67e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—MTHFR—polycystic ovary syndrome	1.53e-05	5.66e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—SULT2A1—polycystic ovary syndrome	1.5e-05	5.55e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—LHB—polycystic ovary syndrome	1.49e-05	5.52e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—CYP1A1—polycystic ovary syndrome	1.49e-05	5.51e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—RRM2—polycystic ovary syndrome	1.48e-05	5.5e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—TH—polycystic ovary syndrome	1.48e-05	5.47e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—HSD3B2—polycystic ovary syndrome	1.46e-05	5.4e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—RRM2—polycystic ovary syndrome	1.45e-05	5.38e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—PPARG—polycystic ovary syndrome	1.45e-05	5.36e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—SLC2A4—polycystic ovary syndrome	1.44e-05	5.33e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—YAP1—polycystic ovary syndrome	1.43e-05	5.3e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PPARG—polycystic ovary syndrome	1.42e-05	5.25e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—SULT2A1—polycystic ovary syndrome	1.42e-05	5.25e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—AKR1C1—polycystic ovary syndrome	1.41e-05	5.23e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—YAP1—polycystic ovary syndrome	1.4e-05	5.18e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—POMC—polycystic ovary syndrome	1.4e-05	5.18e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	1.39e-05	5.17e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—INS—polycystic ovary syndrome	1.39e-05	5.15e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—MTHFR—polycystic ovary syndrome	1.39e-05	5.14e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—NAMPT—polycystic ovary syndrome	1.38e-05	5.1e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—RRM2—polycystic ovary syndrome	1.37e-05	5.08e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	1.36e-05	5.04e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	1.36e-05	5.04e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CYP11A1—polycystic ovary syndrome	1.36e-05	5.03e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—TH—polycystic ovary syndrome	1.35e-05	5.02e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CYP19A1—polycystic ovary syndrome	1.35e-05	5.01e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—NAMPT—polycystic ovary syndrome	1.34e-05	4.98e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	1.33e-05	4.93e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CYP11A1—polycystic ovary syndrome	1.33e-05	4.92e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—YAP1—polycystic ovary syndrome	1.32e-05	4.9e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—SLC2A4—polycystic ovary syndrome	1.32e-05	4.88e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.31e-05	4.87e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—SERPINE1—polycystic ovary syndrome	1.3e-05	4.82e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—SULT2A1—polycystic ovary syndrome	1.3e-05	4.81e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—AKR1C3—polycystic ovary syndrome	1.28e-05	4.75e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—NAMPT—polycystic ovary syndrome	1.27e-05	4.71e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CYP17A1—polycystic ovary syndrome	1.26e-05	4.68e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.26e-05	4.68e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—RRM2—polycystic ovary syndrome	1.26e-05	4.66e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CYP11A1—polycystic ovary syndrome	1.25e-05	4.65e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—AKR1C3—polycystic ovary syndrome	1.25e-05	4.65e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.25e-05	4.62e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.25e-05	4.61e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PPARG—polycystic ovary syndrome	1.24e-05	4.59e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CYP19A1—polycystic ovary syndrome	1.24e-05	4.59e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CYP17A1—polycystic ovary syndrome	1.23e-05	4.57e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—POMC—polycystic ovary syndrome	1.22e-05	4.53e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—INS—polycystic ovary syndrome	1.21e-05	4.5e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	1.21e-05	4.49e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	1.21e-05	4.49e-05	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—IL6—polycystic ovary syndrome	1.21e-05	4.49e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—GNAS—polycystic ovary syndrome	1.21e-05	4.47e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	1.19e-05	4.39e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—AKR1C3—polycystic ovary syndrome	1.18e-05	4.39e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CYP17A1—polycystic ovary syndrome	1.17e-05	4.32e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	1.16e-05	4.31e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.16e-05	4.29e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	1.15e-05	4.26e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—NCOR1—polycystic ovary syndrome	1.15e-05	4.26e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	1.15e-05	4.25e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.14e-05	4.23e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	1.14e-05	4.23e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PPARG—polycystic ovary syndrome	1.12e-05	4.16e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—POMC—polycystic ovary syndrome	1.11e-05	4.11e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—GNAS—polycystic ovary syndrome	1.11e-05	4.1e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—INS—polycystic ovary syndrome	1.1e-05	4.08e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—TH—polycystic ovary syndrome	1.09e-05	4.05e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CYP1A1—polycystic ovary syndrome	1.09e-05	4.04e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	1.09e-05	4.02e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	1.08e-05	4.01e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	1.07e-05	3.96e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—TH—polycystic ovary syndrome	1.07e-05	3.96e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—SLC2A4—polycystic ovary syndrome	1.06e-05	3.94e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	1.06e-05	3.91e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—NCOR1—polycystic ovary syndrome	1.05e-05	3.9e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—SLC2A4—polycystic ovary syndrome	1.04e-05	3.85e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	1.03e-05	3.82e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	1.02e-05	3.79e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—MTHFR—polycystic ovary syndrome	1.02e-05	3.76e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—TH—polycystic ovary syndrome	1.01e-05	3.74e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CYP19A1—polycystic ovary syndrome	9.99e-06	3.7e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CYP1A1—polycystic ovary syndrome	9.98e-06	3.7e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	9.86e-06	3.65e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—SLC2A4—polycystic ovary syndrome	9.81e-06	3.64e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CYP19A1—polycystic ovary syndrome	9.77e-06	3.62e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	9.47e-06	3.51e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	9.42e-06	3.49e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	9.36e-06	3.47e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—MTHFR—polycystic ovary syndrome	9.31e-06	3.45e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	9.29e-06	3.44e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—TH—polycystic ovary syndrome	9.25e-06	3.43e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CYP19A1—polycystic ovary syndrome	9.23e-06	3.42e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	9.19e-06	3.41e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	9e-06	3.33e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GNAS—polycystic ovary syndrome	8.92e-06	3.31e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	8.84e-06	3.27e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	8.77e-06	3.25e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	8.72e-06	3.23e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	8.7e-06	3.22e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—NCOR1—polycystic ovary syndrome	8.5e-06	3.15e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	8.46e-06	3.13e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	8.3e-06	3.08e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GNAS—polycystic ovary syndrome	8.24e-06	3.05e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PPARG—polycystic ovary syndrome	8.23e-06	3.05e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—POMC—polycystic ovary syndrome	8.12e-06	3.01e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—INS—polycystic ovary syndrome	8.07e-06	2.99e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CYP1A1—polycystic ovary syndrome	8.05e-06	2.98e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	8e-06	2.96e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	7.87e-06	2.92e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—NCOR1—polycystic ovary syndrome	7.85e-06	2.91e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	7.82e-06	2.9e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	7.57e-06	2.81e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	7.55e-06	2.8e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PPARG—polycystic ovary syndrome	7.55e-06	2.8e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—TH—polycystic ovary syndrome	7.53e-06	2.79e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—MTHFR—polycystic ovary syndrome	7.51e-06	2.78e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—POMC—polycystic ovary syndrome	7.44e-06	2.76e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—INS—polycystic ovary syndrome	7.4e-06	2.74e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	7.34e-06	2.72e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	7.32e-06	2.71e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	7.19e-06	2.67e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	6.97e-06	2.58e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—MTHFR—polycystic ovary syndrome	6.93e-06	2.57e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	6.88e-06	2.55e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	6.82e-06	2.53e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	6.75e-06	2.5e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	6.5e-06	2.41e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	6.36e-06	2.36e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	6.25e-06	2.32e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	6.17e-06	2.29e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	6.14e-06	2.28e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PPARG—polycystic ovary syndrome	6.09e-06	2.26e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—POMC—polycystic ovary syndrome	6e-06	2.23e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—INS—polycystic ovary syndrome	5.97e-06	2.21e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	5.95e-06	2.21e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	5.87e-06	2.18e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	5.85e-06	2.17e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—INS—polycystic ovary syndrome	5.84e-06	2.16e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	5.83e-06	2.16e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	5.74e-06	2.13e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PPARG—polycystic ovary syndrome	5.62e-06	2.08e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	5.55e-06	2.06e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—POMC—polycystic ovary syndrome	5.54e-06	2.05e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—INS—polycystic ovary syndrome	5.51e-06	2.04e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	5.17e-06	1.92e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	5.15e-06	1.91e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	5.08e-06	1.88e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—INS—polycystic ovary syndrome	5.06e-06	1.87e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—TH—polycystic ovary syndrome	4.96e-06	1.84e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	4.83e-06	1.79e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	4.54e-06	1.68e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	4.19e-06	1.55e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	4.14e-06	1.53e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—INS—polycystic ovary syndrome	4.11e-06	1.52e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	4.05e-06	1.5e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	3.86e-06	1.43e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	3.66e-06	1.36e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	3.41e-06	1.26e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	2.77e-06	1.03e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	2.73e-06	1.01e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—INS—polycystic ovary syndrome	2.71e-06	1.01e-05	CbGpPWpGaD
